Self.made billionaire Sean Parker continues his vision on advancing medical researches. His Parker Institute for Cancer Immunotherapy collaborated with the Cancer Research Institute in an effort to use algorith in uncovering neoantigens.
immunotherapy
Breaking News
Bristol-Myers Squibb Co on Thursday filed a lawsuit against Merck & Co Inc for allegedly infringing its immunotherapy patent. The company is seeking unspecified damages.
Switzerland-based drug manufacturer Novartis will be buying closely-held Massachusetts-based biotechnology firm so it will grow its range of immunotherapeutics products to treat cancer, Bloomberg reported.
Subscribe to VCpost newsletter
Most Popular
- Nestle Cuts Sales Forecast as Shoppers Reject Price Hikes
- Social Security Payments Worth Over $4,800 To Go Out This Week; Here’s When You’ll Get Yours
- US Could See Another ‘Great Resignation’ as 3 in 10 Workers Plan To Quit in 2024: Survey
- Uber, Lyft Drivers Remain as Contractors After California Supreme Court Upheld Proposition 22
- Maersk Agrees to Settlement with US Labor Department After Firing Whistleblower
- Walmart Eyes $200 Million Investment in Autonomous Forklifts
- Delta’s CEO Flew to Paris for the Olympics While His Company Is Under Federal Investigation: Report
- Wiers Farm Recalls Produce Products Due To Potential Listerian Contamination